Skip to content

Understanding Local Determinants of Cardiovascular Disease and Diabetes

Understanding Local Determinants of Cardiovascular Disease and Diabetes to Inform Novel Interventional Strategies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03422185
Enrollment
28891
Registered
2018-02-05
Start date
2013-05-31
Completion date
2015-02-28
Last updated
2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hypertension, Overweight and Obesity

Brief summary

Cross-sectional survey of all adults residing in two defined geographical regions in urban Lilongwe and rural Karonga District. Participants were interviewed, had anthropometric measures taken, and had fasting blood specimens taken.

Interventions

OTHERNo intervention

No intervention

Sponsors

Malawi Epidemiology and Intervention Research Unit
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* all adults over 18 self-identifying as normally resident in the pre-defined geographical areas

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
What is the true burden of hypertension, diabetes, and hyperlipidaemia?By end of 2018Prevalence of hypertension (BP \<140/90 or self-report of antihypertensive use), diabetes (fasting blood glucose \>7.0 or self-report history of diabetes), and hyperlipidaemia

Secondary

MeasureTime frameDescription
What is the prevalence of known risk factors - notably smoking, obesity, physical inactivity, alcohol, salt, and saturated fat intake?By end of 2020Description of prevalence of known risk factors of hypertension, diabetes, and hyperlipidaemia. Dietary salt intake is estimated both by how long a defined quantity of salt is reported to last in a household on average, and from spot urine sodium specimens.
Is infection, notably HIV infection or its therapy, associated with increased risk of NCDs?By end of 2020Description of HIV infection and its therapy in relationship to hypertension, diabetes and hyperlipidaemia

Countries

Malawi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026